Free Trial

Definitive Healthcare (DH) Competitors

Definitive Healthcare logo
$0.92 +0.04 (+4.47%)
As of 03:04 PM Eastern
This is a fair market value price provided by Massive. Learn more.

DH vs. MTLS, XNET, SMWB, BLND, and MIXT

Should you buy Definitive Healthcare stock or one of its competitors? MarketBeat compares Definitive Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Definitive Healthcare include Materialise (MTLS), Xunlei (XNET), Similarweb (SMWB), Blend Labs (BLND), and MiX Telematics (MIXT). These companies are all part of the "computer software" industry.

How does Definitive Healthcare compare to Materialise?

Definitive Healthcare (NASDAQ:DH) and Materialise (NASDAQ:MTLS) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.

In the previous week, Materialise had 2 more articles in the media than Definitive Healthcare. MarketBeat recorded 3 mentions for Materialise and 1 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.93 beat Materialise's score of 0.83 indicating that Definitive Healthcare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Definitive Healthcare
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Materialise
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Materialise has a net margin of 3.77% compared to Definitive Healthcare's net margin of -76.04%. Materialise's return on equity of 4.05% beat Definitive Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Definitive Healthcare-76.04% 4.04% 1.99%
Materialise 3.77%4.05%2.47%

Definitive Healthcare presently has a consensus price target of $2.77, indicating a potential upside of 201.71%. Materialise has a consensus price target of $10.00, indicating a potential upside of 47.49%. Given Definitive Healthcare's higher possible upside, equities research analysts clearly believe Definitive Healthcare is more favorable than Materialise.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Definitive Healthcare
3 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.00
Materialise
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Definitive Healthcare has a beta of 1.33, indicating that its stock price is 33% more volatile than the broader market. Comparatively, Materialise has a beta of 1.33, indicating that its stock price is 33% more volatile than the broader market.

98.7% of Definitive Healthcare shares are held by institutional investors. Comparatively, 19.3% of Materialise shares are held by institutional investors. 17.1% of Definitive Healthcare shares are held by insiders. Comparatively, 1.2% of Materialise shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Materialise has higher revenue and earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than Materialise, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Definitive Healthcare$241.52M0.40-$138.93M-$1.62N/A
Materialise$302.73M1.32$8.73M$0.2033.90

Summary

Materialise beats Definitive Healthcare on 10 of the 15 factors compared between the two stocks.

How does Definitive Healthcare compare to Xunlei?

Definitive Healthcare (NASDAQ:DH) and Xunlei (NASDAQ:XNET) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.

Definitive Healthcare has a beta of 1.33, meaning that its share price is 33% more volatile than the broader market. Comparatively, Xunlei has a beta of 1.1, meaning that its share price is 10% more volatile than the broader market.

Definitive Healthcare currently has a consensus price target of $2.77, suggesting a potential upside of 201.71%. Given Definitive Healthcare's higher probable upside, analysts plainly believe Definitive Healthcare is more favorable than Xunlei.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Definitive Healthcare
3 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.00
Xunlei
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Xunlei has higher revenue and earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than Xunlei, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Definitive Healthcare$241.52M0.40-$138.93M-$1.62N/A
Xunlei$462.41M0.67$1.05B$13.670.36

In the previous week, Xunlei had 4 more articles in the media than Definitive Healthcare. MarketBeat recorded 5 mentions for Xunlei and 1 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.93 beat Xunlei's score of 0.50 indicating that Definitive Healthcare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Definitive Healthcare
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Xunlei
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 5.1% of Xunlei shares are owned by institutional investors. 17.1% of Definitive Healthcare shares are owned by insiders. Comparatively, 21.7% of Xunlei shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Xunlei has a net margin of 185.71% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Xunlei's return on equity.

Company Net Margins Return on Equity Return on Assets
Definitive Healthcare-76.04% 4.04% 1.99%
Xunlei 185.71%1.47%1.24%

Summary

Definitive Healthcare and Xunlei tied by winning 8 of the 16 factors compared between the two stocks.

How does Definitive Healthcare compare to Similarweb?

Similarweb (NYSE:SMWB) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership.

Similarweb has higher revenue and earnings than Definitive Healthcare. Similarweb is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Similarweb$282.60M1.37-$32.94M-$0.35N/A
Definitive Healthcare$241.52M0.40-$138.93M-$1.62N/A

In the previous week, Similarweb had 6 more articles in the media than Definitive Healthcare. MarketBeat recorded 7 mentions for Similarweb and 1 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.93 beat Similarweb's score of 0.72 indicating that Definitive Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Similarweb
2 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Definitive Healthcare
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Similarweb has a beta of 1.25, suggesting that its stock price is 25% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.33, suggesting that its stock price is 33% more volatile than the broader market.

57.6% of Similarweb shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 62.4% of Similarweb shares are held by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Similarweb has a net margin of -10.38% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Similarweb's return on equity.

Company Net Margins Return on Equity Return on Assets
Similarweb-10.38% -48.57% -4.45%
Definitive Healthcare -76.04%4.04%1.99%

Similarweb presently has a consensus price target of $7.07, suggesting a potential upside of 60.53%. Definitive Healthcare has a consensus price target of $2.77, suggesting a potential upside of 201.71%. Given Definitive Healthcare's higher possible upside, analysts plainly believe Definitive Healthcare is more favorable than Similarweb.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Similarweb
1 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.18
Definitive Healthcare
3 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.00

Summary

Similarweb beats Definitive Healthcare on 9 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to Blend Labs?

Definitive Healthcare (NASDAQ:DH) and Blend Labs (NYSE:BLND) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 52.6% of Blend Labs shares are owned by institutional investors. 17.1% of Definitive Healthcare shares are owned by company insiders. Comparatively, 40.3% of Blend Labs shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Definitive Healthcare and Definitive Healthcare both had 1 articles in the media. Definitive Healthcare's average media sentiment score of 0.93 beat Blend Labs' score of 0.62 indicating that Definitive Healthcare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Definitive Healthcare
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Blend Labs
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Definitive Healthcare has a beta of 1.33, meaning that its share price is 33% more volatile than the broader market. Comparatively, Blend Labs has a beta of 1.09, meaning that its share price is 9% more volatile than the broader market.

Blend Labs has lower revenue, but higher earnings than Definitive Healthcare. Blend Labs is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Definitive Healthcare$241.52M0.40-$138.93M-$1.62N/A
Blend Labs$123.51M3.38-$6.80M-$0.10N/A

Definitive Healthcare presently has a consensus price target of $2.77, suggesting a potential upside of 201.71%. Blend Labs has a consensus price target of $3.32, suggesting a potential upside of 92.27%. Given Definitive Healthcare's higher possible upside, equities analysts plainly believe Definitive Healthcare is more favorable than Blend Labs.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Definitive Healthcare
3 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.00
Blend Labs
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43

Blend Labs has a net margin of -3.72% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Blend Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Definitive Healthcare-76.04% 4.04% 1.99%
Blend Labs -3.72%N/A -1.63%

Summary

Definitive Healthcare beats Blend Labs on 9 of the 16 factors compared between the two stocks.

How does Definitive Healthcare compare to MiX Telematics?

MiX Telematics (NYSE:MIXT) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership, risk and media sentiment.

MiX Telematics has a net margin of 3.72% compared to Definitive Healthcare's net margin of -76.04%. MiX Telematics' return on equity of 8.45% beat Definitive Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
MiX Telematics3.72% 8.45% 5.11%
Definitive Healthcare -76.04%4.04%1.99%

Definitive Healthcare has a consensus target price of $2.77, indicating a potential upside of 201.71%. Given Definitive Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Definitive Healthcare is more favorable than MiX Telematics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MiX Telematics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Definitive Healthcare
3 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.00

MiX Telematics has a beta of 1.15, indicating that its share price is 15% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.33, indicating that its share price is 33% more volatile than the broader market.

In the previous week, Definitive Healthcare had 1 more articles in the media than MiX Telematics. MarketBeat recorded 1 mentions for Definitive Healthcare and 0 mentions for MiX Telematics. Definitive Healthcare's average media sentiment score of 0.93 beat MiX Telematics' score of 0.00 indicating that Definitive Healthcare is being referred to more favorably in the news media.

Company Overall Sentiment
MiX Telematics Neutral
Definitive Healthcare Positive

45.7% of MiX Telematics shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 12.4% of MiX Telematics shares are held by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

MiX Telematics has higher earnings, but lower revenue than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than MiX Telematics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MiX Telematics$150.06M2.36$4.52M$0.2558.20
Definitive Healthcare$241.52M0.40-$138.93M-$1.62N/A

Summary

Definitive Healthcare beats MiX Telematics on 10 of the 17 factors compared between the two stocks.

Get Definitive Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for DH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DH vs. The Competition

MetricDefinitive HealthcareINTERNET SOFTWARE IndustryComputer SectorNASDAQ Exchange
Market Cap$96.45M$17.81B$40.67B$12.49B
Dividend YieldN/A2.91%3.06%5.22%
P/E Ratio-0.5664.5782.5924.42
Price / Sales0.4044.73634.93117.04
Price / Cash0.4980.6053.0357.13
Price / Book0.346.5410.216.74
Net Income-$138.93M$386.39M$1.06B$337.03M
7 Day Performance3.32%2.42%2.54%0.24%
1 Month PerformanceN/AN/AN/A-1.67%
1 Year Performance-74.17%-2.90%170.56%34.36%

Definitive Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DH
Definitive Healthcare
2.3806 of 5 stars
$0.92
+4.5%
$2.77
+201.7%
-74.8%$96.45M$241.52MN/A970
MTLS
Materialise
3.6339 of 5 stars
$6.11
+3.6%
$10.00
+63.7%
+23.3%$360.92M$302.73M30.552,556
XNET
Xunlei
1.5939 of 5 stars
$5.71
+4.2%
N/A-14.3%$358.87M$462.41M0.351,306
SMWB
Similarweb
3.7594 of 5 stars
$4.07
-1.5%
$7.07
+73.7%
-41.4%$356.53M$282.60MN/A1,085
BLND
Blend Labs
3.7919 of 5 stars
$1.47
-0.3%
$3.32
+126.4%
-57.0%$354.71M$123.51MN/A1,690

Related Companies and Tools


This page (NASDAQ:DH) was last updated on 6/4/2026 by MarketBeat.com Staff.
From Our Partners